Cancer Drug Approvals Highlight SPT Week in Review

Author(s):

Top articles of the week on Specialty Pharmacy Times.

5. FDA Greenlights Combination Treatment for Metastatic NSCLC with BRAF V600E Mutation

A next generation sequencing test to detect lung cancer mutation was also approved.

4. Rituximab Plus Hyaluronidase Combination Approved to Treat Leukemia, Lymphomas

Subcutaneous administration of Rituxan Hycela shortens treatment length to only 5 to 7 minutes.

3. Top 10 Rated Pharmaceutical Companies of 2017

Consumer opinions shape list of top rated pharmaceutical manufacturers based on products and services.

2. Two Investigational Drugs to Treat Psoriatic Arthritis on the Horizon

Tofacitinib and Guselkumab show promise in patients with PsA.

1. Pharmacy Outlook for Independent Pharmacies & Collaborative Practice

Forward-thinking pharmacies can capitalize on the rise of value-based care.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.